farmacêutico

Acompanhamento farmacoterapêutico em pacientes com doença renal crônica

Resumo: Background: Health professionals, in recent decades, have directed greater attention to chronic diseases, since these diseases are responsible for a significant portion of the morbidity of the world population, affecting from young people to the elderly. Currently, the main treatments available for end-stage renal disease are: automated peritoneal dialysis, hemodialysis, continuous ambulatory peritoneal dialysis, intermittent peritoneal dialysis and kidney transplantation. Such treatments partially exert the renal function, alleviating disease symptoms and preserving the patient's life, without generating a cure. Chronic kidney patients use several drugs concomitantly, which, associated with changes in the glomerular filtration rate, multiple comorbidities and age, increase the risk of drug interactions. Objective: The aim of the present study is the pharmacotherapeutic follow-up of patients with chronic kidney disease, aiming at improving their quality of life in this population, which, due to the practice of polypharmacy and the presence of various diseases, usually has their quality of life reduced. Methods: Data present in the patient's medical record and the SOAP (Subjective, Objective, Assessment, Plan) allowed the collection and organization of patient data, the identification of problems related to pharmacotherapy, the elaboration of a care plan together with the patient and put an end to individual follow-up of the patient. Results: Of the 5 patients interviewed, in 1 there was no drug interaction, however, 4 had drug interactions, referring to their pharmacological treatment, totaling 12 interactions, with 6 (50%) severe interactions, 5 (41.67%) moderate and 1 (8 .33%) light. Conclusions: This research allowed to carry out pharmacotherapeutic monitoring in chronic kidney patients, who, due to their condition, have prescription restrictions of different therapeutic classes that can generate adverse effects in relation to renal function and age, resulting in polypharmacy and DRPs. Keywords: kidney disease, pharmacist, interactions. Expandir Resumo Acessar Texto Completo

O papel do farmacêutico no controle do uso racional de antimicrobianos em drogarias

Resumo: Introduction: The ability of bacterial resistance to antibiotics is characterized as the possibility of a bacterium to survive in concentrations of antibiotics that inhibit others of the same species. Review: This study is a literature review based on the synthesis of the main studies published in LILACS and MEDLINE that are part of the Virtual Health Library – VHL collection database. The increase in pathogenic microorganisms that resist antimicrobials due to their infectious potential is increasingly progressive. Once the antimicrobial is prescribed by the responsible physician, the pharmacist is responsible for instructing the administration of the same, which will provide greater safety and efficiency during the patient's treatment. Discussion: To reduce the incidence of antibiotic resistance due to inappropriate use, it is important that the patient has adequate information, especially with regard to not using self-medication. Final considerations: The pharmaceutical action is important in the correct orientation of antimicrobials, being a great challenge. It is essential that you actively participate in the use of medications and provide the patient with the necessary information about antibiotic therapy. Keywords: antimicrobials, resistance, pharmaceutical. Expandir Resumo Acessar Texto Completo

Assistência farmacêutica em unidades hospitalares em tempos de pandemia – uma revisão integrativa

Resumo: Introduction: The COVID-19 pandemic imposed on hospital pharmacists the need to plan and organize a response to the challenges brought about by the disease. Pharmacists exercise fundamental activities in the context of the pandemic, either through the supply of medicines or the provision of pharmaceutical services. Managing pharmacies, hospitals or community, in times of SARS-CoV-2 is a new challenge. The hospital pharmacy has been facing several challenges in the face of the pandemic scenario and, in order to continue offering a quality service to the population, it was necessary to adopt coping strategies and adapt their activities. Thus, this research aims to highlight the importance of pharmacists and pharmacies within hospital units, considering the specificities of the pandemic of COVID-19. Review: This is an exploratory bibliographic review, through an integrative review. The collection of scientific data and the systematization of information come from scientific productions published from 2018 to 2021, in Portuguese, indexed in the database of the BVS, LILACS and SCIELO. Discussion: Hospital pharmacists had to restructure the service in response to COVID-19, considering the need to protect the teams, so that there is no compromise in the care activity and support for medical action and, simultaneously, provide an effective response to the new reality, not neglecting the component of reviewing and monitoring the use of health technologies and active pharmacovigilance of drugs used in the treatment of COVID-19. Final Remarks: It was found that the concept of hospital pharmacy goes beyond a sector of custody of medicines, being a department that adds value to other sectors of the hospital. Thus, the research findings allowed us to conclude that pharmacists, when working in hospital pharmacies, can collaborate with the multiprofessional health team, monitoring the use of medicines and the clinical evolution of patients, since the off-label use of medicines is a current reality that can cause serious damage to the health of individuals. Keywords: pharmaceutical assistance, pharmacist, hospital pharmacy, pandemic. Expandir Resumo Acessar Texto Completo

Erros em prescrições de medicamentos